Clinical Trials Directory

Trials / Sponsors / Guangzhou Jiayin Biotech Ltd

Guangzhou Jiayin Biotech Ltd

Industry · 9 registered clinical trials — 7 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingEvaluating the Safety and Preliminary Efficacy of EXG202 Gene Therapy for Neovascular AMD
Wet Age-related Macular Degeneration
Phase 1 / Phase 22025-10-16
Not Yet RecruitingTo Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovasc
Wet Age-related Macular Degeneration (wAMD), Wet Age-related Macular Degeneration
EARLY_Phase 12025-03-28
RecruitingA Long-term Follow up Study of EXG102-031 in Participants With wAMD
Wet Age-related Macular Degeneration
—2025-03-13
Enrolling By InvitationClinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy
Spinal Muscular Atrophy (SMA)
EARLY_Phase 12025-03-10
Not Yet RecruitingThe Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease
Fabry Disease
Phase 1 / Phase 22025-03-01
Enrolling By InvitationA Long-term Follow-up Study Evaluating Intravenous Injection of EXG001-307 in Patients With Type 1 SMA
Spinal Muscular Atrophy
—2025-03-01
UnknownA Study of EXG102-031 in Participants With wAMD
Neovascular Age-related Macular Degeneration
Phase 1 / Phase 22023-10-12
Enrolling By InvitationClinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal Muscular Atrophy Type 1
Spinal Muscular Atrophy Type I
Phase 1 / Phase 22023-02-16
CompletedClinical Trial to Evaluate the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy Type
Type I Spinal Muscular Atrophy
EARLY_Phase 12022-01-21